EUVIMEDEUVIMED entdecken
Crossref

NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy

Frank G Lee iD, Kristine T Hanson iD, Ashton E Cross iD, Elizabeth B Habermann iD, Cornelius A Thiels iD, Travis E Grotz iD

Journal of Surgical Oncology · 2026-11 · 134 (6) · 947-957

DOI: 10.1002/jso.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 16.08.2026. Verfasst von Frank G Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Gastrectomy, Stomach Neoplasms, Laparoscopy, Robotic Surgical Procedures. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ACS‐NSQIP began capturing operative approach in 2022. With increased adoption of minimally invasive (MIS) techniques for malignancy, a contemporary review of benchmark outcomes for open, laparoscopic and robotic gastrectomy is warranted.

Methods

We performed a retrospective cohort study of adults in ACS‐NSQIP (2022–2024) undergoing partial or total gastrectomy (CPT 43631‐4 and 43620‐2) for cancer. Outcomes included operative time, length of stay (LOS), unplanned conversion‐to‐open, and 30‐day morbidity, mortality, and readmission. Multivariable logistic regression evaluated patient and operative factors associated with morbidity.

Results

Among 1,459 patients (median age 66, 60.4% male), 66.8% underwent partial gastrectomy and 33.2% total gastrectomy. Approaches were 61.2% open, 19.5% laparoscopic, and 19.3% robotic. Thirty‐day mortality (1.8%), major complications (18.2%), and readmissions (10.3%) did not differ by approach. Unplanned conversion‐to‐open occurred in 14.0% of MIS. Robotic had longer median operative time of +1.2 and +1.7 h than laparoscopic and open and median −1 and −2 days shorter LOS respectively ( p < 0.001). Hypoalbuminemia (OR 3.10), CKD ≥ 3 (OR 1.75), and anemia (OR 1.48) were independently associated with major complications ( p < 0.05).

Conclusion

Operative approach influences operative time and LOS but not short‐term morbidity and mortality. The newly available ACS‐NSQIP operative approach variable enables approach‐specific benchmarks for cancer‐related gastrectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastrectomyStomach NeoplasmsLaparoscopyRobotic Surgical ProceduresMinimally Invasive Surgical ProceduresHumansFemaleRetrospective StudiesMaleAgedMiddle AgedLength of StayPostoperative ComplicationsOperative Time

Stichwörter der Autor:innen

benchmarkinggastrectomylaparoscopyquality improvementroboticsstomach neoplasms

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Frank G Lee, Kristine T Hanson, Ashton E Cross, Elizabeth B Habermann, Cornelius A Thiels, Travis E Grotz

Zitieren

APA

Lee, F. G., Hanson, K. T., Cross, A. E., Habermann, E. B., Thiels, C. A., & Grotz, T. E. (2026). NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy. Journal of Surgical Oncology, 134(6), 947-957. https://doi.org/10.1002/jso.70359

Vancouver

Lee FG, Hanson KT, Cross AE, Habermann EB, Thiels CA, Grotz TE. NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy. Journal of Surgical Oncology. 2026;134(6):947-957. doi:10.1002/jso.70359

BibTeX
@article{Lee2026,
  author = {Lee, Frank G and Hanson, Kristine T and Cross, Ashton E and Habermann, Elizabeth B and Thiels, Cornelius A and Grotz, Travis E},
  title = {NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {134},
  number = {6},
  pages = {947--957},
  doi = {10.1002/jso.70359}
}
Kostenlos starten →